Conestoga Capital Advisors’s CryoPort CYRX Stock Holding History

Conestoga Capital Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Sell	158,674 -1,190	-0.7%	-$15.3K	0.05%	69
2026 Q1	$1.32M	Hold	159,864	–	–	0.03%	75
2025 Q4	$1.53M	Buy	159,864 +54,675	+52%	+$517K	0.03%	76
2025 Q3	$997K	Sell	105,189 -5,368	-5%	-$45.2K	0.02%	88
2025 Q2	$825K	Buy	110,557 +39,640	+56%	+$246K	0.01%	93
2025 Q1	$431K	Hold	70,917	–	–	0.01%	110
2024 Q4	$552K	Sell	70,917 -240	-0.3%	-$1.79K	0.01%	106
2024 Q3	$577K	Hold	71,157	–	–	0.01%	104
2024 Q2	$492K	Sell	71,157 -260	-0.4%	-$3.5K	0.01%	112
2024 Q1	$1.26M	Buy	71,417 +690	+1%	+$10.9K	0.02%	84
2023 Q4	$1.1M	Buy	70,727 +2,825	+4%	+$36.9K	0.02%	92
2023 Q3	$931K	Hold	67,902	–	–	0.02%	92
2023 Q2	$1.17M	Buy	67,902 +14,010	+26%	+$287K	0.02%	82
2023 Q1	$1.29M	Hold	53,892	–	–	0.02%	79
2022 Q4	$935K	Buy	53,892 +11,690	+28%	+$246K	0.02%	95
2022 Q3	$1.03M	Hold	42,202	–	–	0.02%	86
2022 Q2	$1.31M	Sell	42,202 -283	-0.7%	-$7.53K	0.02%	81
2022 Q1	$1.48M	Buy	42,485 +13,225	+45%	+$500K	0.02%	82
2021 Q4	$1.73M	Buy	29,260 +60	+0.2%	+$4.15K	0.02%	85
2021 Q3	$1.94M	Sell	29,200 -4,975	-15%	-$307K	0.03%	83
2021 Q2	$2.16M	Buy	34,175 +2,875	+9%	+$162K	0.03%	81
2021 Q1	$1.63M	Sell	31,300 -3,125	-9%	-$190K	0.02%	88
2020 Q4	$1.51M	Buy	34,425 +1,925	+6%	+$91.7K	0.02%	85
2020 Q3	$1.54M	Sell	32,500 -14,100	-30%	-$571K	0.03%	78
2020 Q2	$1.41M	Buy	46,600 +7,180	+18%	+$160K	0.03%	77
2020 Q1	$673K	Sell	39,420 -3,500	-8%	-$61.3K	0.02%	81
2019 Q4	$706K	Buy	42,920 +24,525	+133%	+$365K	0.02%	92
2019 Q3	$301K	Sell	18,395 -3,300	-15%	-$66.1K	0.01%	123
2019 Q2	$397K	Sell	21,695 -5,790	-21%	-$91.9K	0.01%	110
2019 Q1	$355K	Buy	+27,485	New	+$299K	0.01%	114

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Conestoga Capital Advisors's CYRX Position: Q2 2026 in Review

Conestoga Capital Advisors reduced its CryoPort (CYRX) stake by 0.74% in Q2 2026, selling an estimated $15.3K and leaving 158,674 shares worth $2.49M. The position accounts for 0.05% of the portfolio, ranked #69.

Conestoga Capital Advisors first reported a position in CYRX in Q1 2019 and has held it in 30 quarters since. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

Conestoga Capital Advisors held 158,674 shares of CryoPort worth $2.49M as of Q2 2026.
Conestoga Capital Advisors sold 1,190 CryoPort shares in Q2 2026, an estimated $15.3K.
CryoPort made up 0.05% of Conestoga Capital Advisors's portfolio in Q2 2026, its #69 holding.
Conestoga Capital Advisors first reported a position in CryoPort in Q1 2019 and has held it in 30 quarters since.
185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.